Crude cell-free preparations of JM strain Marek's disease virus, obtained from the skin of infected chickens, were studied. Infectious virus survived several freeze-thaw cycles and at least 10 minutes of sonic vibration without appreciable loss of titer. It passed through a Millipore filter membrane with average pore diameter of 300 but not 220 m,L. All infectious virus was sedimented by centrifugation at 5,000 X g for 1 hour. Some virus survived 10-minute treatments at pH 4.0 or 10.0 but not at 3.0 or 11.0. Virus did not lose titer in several months at -65 C, but infectivity was markedly reduced in samples stored at -20 C for 4 months. Inactivation was complete within 2 weeks at 4 C, 4 days at 22-25 C, 18 hours at 37 C, 30 minutes at 56 C, and 10 minutes at 60 C. Virus was neutralized by specific antibody, and parallel virus titrations in chicks and cell cultures indicated about equal sensitivity for assays in the two host systems.
INTRODUCTION

Most present information on Marek's disease (MD) virus was
gained through the study of cell-associated infectivity (2,10,12). Thus, many of the reported characteristics were those of the host cell rather than of the virus, e.g., treatments detrimental to cells destroyed infectivity in a preparation.
The discovery that infectious cell-free preparations of virus could be obtained in the form of crude skin extracts from MD-infected birds (4,8,13,14) permitted the study of some characteristics of the virus itself. It is especially important to learn the effects of certain treatments on virus so that laboratory manipulation can be appropriately regulated. Thus, the studies reported herein were largely concerned with some of the more common manipulative treatments. Also, we wished to establish the comparative sensitivity of cell cultures and chicks for assay purposes and to learn if the crude virus preparations might be useful for studies on serumneutralizing antibody.
MATERIALS AND METHODS
Virus. Two cell-free preparations of Marek's disease virus were employed. Each was prepared from the skin of several paralyzed 4-to-6-week-old S-strain (11) birds which had been infected with the JM strain (15) of virus by intra-abdominal inoculation with infected blood and tumor cells at 1 day of age or by continuous direct contact with inoculated chicks. Feathers were clipped off close to the skin, and strips of skin were collected from the major feather areas. The harvested skin was minced with scissors, diluted (w/v) 1:5 (Batch X-300) or 1:10 (Batch X-311) in phosphate-buffered saline (PBS), pH 6.8, containing 500 units penicillin, 500 ,ag streptomycin, and 200 units nystatin per ml. The suspensions were first homogenized for 5 minutes with the macro attachment of a Sorvall Omnimix (Ivan Sorvall, Norwalk, Conn.), and then sonically vibrated for 2 minutes with a Sonifier Cell Disrupter, model W 140 D (Heat Systems-Ultrasonics, Inc., Plainview, L.I., N.Y.) After clarification by centrifugation at 650 g for 10 or 15 minutes, the supernatant fluids were frozen and stored at -65 C. They were considered free of viable cells. Virus titrations indicated about 2,800 and 1,300 focus-forming units (FFU) per ml for batches X-300 and X-311, respectively.
In vitro assays. The preparation and handling of cell cultures, the media, and the methods of determining titers were generally as reported previously (7). About 2.5 to 3.0 million chick kidney (CK) cells in 5 ml medium were seeded per 50-mm plastic Petri dish. Incubation was at 38 to 39 C in a CO2 humidified incubator. At 24 hours, cells had attached and begun to spread but monolayers were not achieved until about 48 hours after seeding.
Virus dilutions were made in PBS or SPGA, a stabilizer (3) containing sucrose, sodium glutamate, and bovine serum albumin in phosphate buffer. When an improved assay method (1,5) became available, 0.2% disodium ethylenediaminetetraacetate (EDTA) was added to these diluents.
Virus assays were conducted by inoculating 0.25 ml of virus suspension onto each of 2 drained 24-hour cultures. After 30 min- Sonic vibration. Batch X-300 virus was employed undiluted and after 1:2 and 1:5 dilution in PBS. Five-ml samples in 16 X 150-mm glass tubes were held in an ice bath. The microprobe of the Sonifier Cell Disrupter was inserted into the suspension to a depth of 1 to 2 cm, and sonic vibration was carried out with a power setting of 25. For treatment periods longer than 1 minute, the treatment was interrupted to allow cooling for 30-60 seconds after each minute of sonic vibration. Percent virus survival was based on the titer of untreated samples.
Freeze-thaw cycles. Assays were done on Batch B-300 virus immediately after thawing and on aliquots which were then refrozen to -65 C, thawed, and warmed to 37 C, 1 to 4 times during a 4-hour period. As a control, 1 sample was held for the same 4-hour period in an ice bath. Percent virus survival was based on the titer of the virus assayed immediately after thawing. pH treatment. Five-ml samples of Batch X-311 virus (original pH, 6.8) were adjusted to desired pH by adding 0.05N HC1 or 0.05N NaOH. After a 10-minute holding period at room temperature, pH was readjusted to neutrality with the same reagents, and the total volume of each sample was brought to 7.5 ml by adding PBS. Before assay, each sample was diluted 1:5 in PBS, pH 6.8, containing 0.2% EDTA.
Filtration. Batch X-311 virus was diluted 1:5 in PBS, pH 6.8, with 0.2% EDTA, and then clarified by centrifugation at 480 X g for 15 minutes. The supernatant fluid was collected, and samples were passed through Millipore filter membranes (Millipore Filter Corp., Bedford, Massachusetts) with average pore diameters of 650, 450, 300, and 220 mtL. All filter membranes were presoaked with fetal bovine serum. Percentage virus recovery was based on the titer of unfiltered virus suspension.
Virus neutralization. Reagents for virus-neutralization tests consisted of undiluted Batch X-300 virus and serum (or the gammaglobulin fraction of serum) diluted in PBS. One part of serum dilution was added to 4 parts of virus suspension, and the mixture was incubated at 37 C for 30 minutes before assay. For a virus control, PBS was substituted for serum.
Negative control serum was a pool from a group of isolated PDRC birds shown to be negative for MD antibody in repeated agar-gel precipitin (AGP) tests. Two positive serum pools were employed; both were from mature birds in the departmental (PDRC) flock free of all known avian pathogens except MD. The gamma-globulin fraction of one pool was obtained by precipitation with half-saturated ammonium sulfate, and, after dialysis against physiological saline, it was diluted to contain 1%o protein. Hyperimmune infectious bronchitis serum and Newcastle disease serum were kindly supplied by Mr. Barrett Cowen, of this department. All of the serums also were tested in the agar gel precipitin test (9), with antigen prepared from the skin of JM-virus-infected S-strain birds (8).
RESULTS
Thermal inactivation. Batch X-300 virus, stored at -65 C, was assayed on 5 occasions during a 210-day period beginning 2 days after preparation. Titers ranged from 2,160 to 2,840 FFU/ml (average, 2,280); no loss of infectivity was associated with storage at that temperature. On the other hand, virus stored at -20 C dropped appreciably in titer. By 4 weeks, only 50.6% of the original infectivity remained. At 14 weeks and 16 weeks, the respective percentages of surviving virus were 5.5% and 2.4%. Freeze-thaw cycles. Infectious virus survived 4 freeze-thaw cycles without a titer reduction (see Table 2 ). pH treatment. In two trials (Table 3) , some virus survived a 10-minute treatment at pH 4.0 or 10.0 although titers were low in those samples. No virus was detected in samples adjusted to pH 3.0 (2 trials) or 11.0 (1 trial). The amount of titer reduction appeared to be related directly to the degree of acidity or alkalinity to which virus was subjected. Filtration. Virus readily passed through a filter membrane of 650-m/A average pore diameter (APD), and a small proportion of the infectious virus was recovered in the 300-m/A-APD membrane filtrate (see Table 4 ).
Centrifugation. Two trials were done in which Batch X-311 virus was diluted 1:5 in PBS with 0.2% EDTA, subjected to an initial low-speed centrifugation (480 or 1,000 X g) for clarification, and then to a higher-velocity centrifugation of 5,000 to 48,000 X g. The data (Table 5) Neutralization. Table 6 contains data from virus neutralization Table 7 . The two systems appeared about equal in sensitivity; approximately 1 FFU in cell-culture assay was equivalent to 1 infectious unit for chicks under the conditions employed.
DISCUSSION
The data presented are generally self-explanatory, although a few points require comment. First, it should be pointed out that the virus suspensions studied were relatively crude preparations and, as such, undoubtedly contained a great deal of nonviral protein, lipid, and other skin-derived materials, which may have influenced the ability of virus to survive various treatments. Nonetheless the
